DPDPE-UK14,304 synergy is retained in mu opioid receptor knockout mice
- 1 July 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Pain
- Vol. 104 (1) , 209-217
- https://doi.org/10.1016/s0304-3959(03)00007-1
Abstract
When agonists to α2adrenergic receptor (AR) and δ opioid receptor (DOR) are co-administered, they act synergistically to inhibit nociceptive elicited behavior. Some previous studies of synergism have used the DOR-selective agonist [d-Pen2,d-Pen5]-enkehphalin (DPDPE), however, DPDPE has beenKeywords
This publication has 34 references indexed in Scilit:
- α2C-Adrenergic Receptors Mediate Spinal Analgesia and Adrenergic-Opioid SynergyThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Heterodimerization of μ and δ Opioid Receptors: A Role in Opiate SynergyJournal of Neuroscience, 2000
- δ-Opioid receptor agonists produce antinociception and [35S]GTPγS binding in μ receptor knockout miceEuropean Journal of Pharmacology, 2000
- Dual ultrastructural immunocytochemical labeling of μ and δ opioid receptors in the superficial layers of the rat cervical spinal cordBrain Research, 1997
- Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cordJournal of Neuroscience, 1995
- delta-Opioid receptor immunoreactivity: distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalinJournal of Neuroscience, 1995
- Morphine reduces the release of met-enkephalin-like material from the rat spinal cord in vivo by acting at ∂ opioid receptorsNeuropeptides, 1994
- Immunofluorescent indentification of a delta (δ)-opioid receptor on primary afferent nerve terminalsNeuroReport, 1993
- Antinociceptive interactions of opioid delta receptor agonists with morphine in mice: Supra- and sub-additivityLife Sciences, 1992
- Opioid δ-receptor involvement in supraspinal and spinal antinociception in miceBrain Research, 1987